|
|
|
| home > white papers > Convergence in the Pharmaceutical Market - PCI Pharma Services |
|
|
 WHITE PAPERS |
|
PCI Pharma Services
|
|
Convergence in the Pharmaceutical Market
|
|
Convergence is currently playing a large part in the growth of the pharmaceutical market. The need for convergence is due to many factors including the declining economy and high competition within the sector. There are many convergences within this sector to date; these include the convergence of food based products with medical and health products and the convergence of prescription drugs to over the counter (OTC) products. Although convergence is helping the pharmaceutical industry expand and develop, it also poses some challenges; these include the regulatory outlook and counterfeiting.
|
|
|
|
|
|
|
 |
News and Press Releases |
 |
Sphere Fluidics closes a $40 million funding round led by Sofinnova Partners and Redmile Group
Cambridge, UK, 28 October 2021: Sphere Fluidics, a company that
has developed and is commercialising single cell analysis systems
underpinned by its proprietary picodroplet technology, announced today
that it has closed a $40 million (circa £30 million) investment round.
The round was led by Sofinnova Partners (Paris, France) and Redmile
Group (San Francisco, USA) co-investing on equal terms.
More info >> |
|
 |
White Papers |
 |
|
CRSF Label - Child-Resistant Blister Packs With Booklet Label
Faubel & Co. Nachfolger GmbH
This case study explains how Faubel was commissioned by a leading global
pharmaceutical company to develop a label for an aluminum blister pack
with 14 cavities, which was used as part of a multinational clinical
trial. This label was intended to both protect infants from erroneous
ingestion and facilitate use by seniors.
More info >> |
|
|
|
